OTC Pediatric Healthcare Market Research Report Presents Growth Opportunity and Trends Insights through the 2017-2022 including Marketplace Classification and Supportive Factors in Healthcare Industry

Dublin, Ireland, 2018-Jul-25 — (Over-The-Counter) OTC pediatric medication is based on self-care or self-diagnosis, hence, OTC pediatric drugs can result into side-effects or allergic reactions. Various risks associated with OTC medicines is impacting its demand in the market. Moreover, some of the leading association across the globe don’t recommend OTC medicines, especially for children as it can result in some serious side-effects. However, producers of OTC drugs are focusing on providing vital information related to the drug dosage, uses, etc., especially for children in order to minimize the risk. This FactMR report analyzes the expansion of global OTC Pediatric Healthcare Market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

The scope of FactMR’s report is to analyze the global OTC pediatric healthcare market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global OTC pediatric healthcare market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to OTC pediatric healthcare.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=257

Over-The-Counter (OTC) medicines can be purchased without doctor’s prescription. OTC drugs are used to treat minor ailments and are usually consumed on basis of self-diagnosis. These drugs are available at pharmacies, small convenience stores as well as at supermarkets. OTC medication is usually not recommended, especially in case of children as they are more likely to have adverse drug reactions than adults. The adverse effects wrong medicine or overdosage can result in an allergic reaction and other side-effects.

OTC medicines have a low risk if used properly by adults, but these drugs pose greater risks for children, especially in the case of first-time medication or if a child is suffering from some other health conditions. According to the U.S. Food and Drug Administration (FDA), OTC medicines to treat cold and cough for children under 2 years of age should be avoided as these medicines can cause serious or life-threatening side-effects. FDA also warns against the use of codeine products to treat cold and cough in children less than 12 years of age as it can result in serious breathing problems. OTC medicines including aspirin are also not recommended for children as aspirin can lead to Reye’s syndrome in children, which is a rear but potentially serious illness.

According to the latest report by Fact.MR, the global market for OTC pediatric healthcare is anticipated to reach close to US$ 10,000 million revenue by 2022 end. The market is expected to experience sluggish growth during the forecast period, 2017 to 2022. Increasing risk of serious side-effects due to OTC medicines based on self-care decision is restricting the parents from choosing OTC drugs for children, thus leading to the decline in OTC pediatric healthcare.

OTC pediatric medicines that fall under dermatology are projected to remain top-selling products in the global OTC pediatric healthcare market between 2017 and 2022. Sale of Dermatology OTC pediatric drugs is expected to bring in nearly US$ 3,500 million revenues towards the end of 2022. Meanwhile, ENT OTC pediatric medicines are anticipated to account for lowest revenue shares.

To know the Latest Trends in OTC Pediatric Healthcare Market, Visit – https://www.factmr.com/report/257/otc-pediatric-healthcare-market

Accounting for nearly one-third of revenue share in the OTC pediatric healthcare, drug stores/ Pharmacies emerge as one of the most lucrative sales channels. Towards the end of 2022, drug stores/ pharmacies are projected to reach close to US$ 3,200 million revenues. Although, global sales of OTC pediatric medicines through hospital pharmacies is projected to create an incremental opportunity of over US$ 300 million during 2017-2022.

OTC Pediatric Healthcare Market: Key Companies

The report also profiles companies that are expected to remain active in the expansion of global OTC pediatric healthcare market through 2022, which include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer Aktiengesellschaft, Sanofi, Pfizer, Inc., Reckitt Benckiser Group plc, and Church & Dwight Co., Inc.

Table of Contents

Global OTC Pediatric Healthcare Market - Executive Summary
Global OTC Pediatric Healthcare Market Overview
2.1. Introduction

       2.1.1. Global OTC Pediatric Healthcare Market Taxonomy

       2.1.2. Global OTC Pediatric Healthcare Market Definition

2.2. Global OTC Pediatric Healthcare Market Size (US$ Mn) and Forecast, 2012-2022

       2.2.1. Global OTC Pediatric Healthcare Market Y-o-Y Growth

2.3. Global OTC Pediatric Healthcare Market Dynamics

       2.3.1. Drivers

       2.3.2. Restraints

       2.3.3. Trends

2.4. Supply Chain

2.5. Cost Structure

2.6. Pricing Analysis

2.7. Raw Material Sourcing Strategy and Analysis

2.8. List of Distributors

Continued………………………………………..

To Buy Global Market Research Report, Check the link – https://www.factmr.com/checkout/257/S

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Sports market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us -

FactMR
Suite 9884
27 Upper Pembroke Street, Dublin 2, Ireland
Telephone @ +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/

This release was published on openPR.